APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Immunomodulators

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Veterinary Immunomodulators Industry Growth and Trends Forecast to 2032

Report ID 174046120126 December 202599 pages

Choose your research edition.

Industry ResearchVeterinary Immunomodulators Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Immunomodulators Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Veterinary Immunomodulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Immunomodulators Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Immunomodulators Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Immunomodulators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Veterinary Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Veterinary Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Immunomodulators include Biogenesis Bago, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Elanco Animal Health, ImmunoVet Ltd., MSD Animal Health, Phibro Animal Health Corporation, Vetoquinol S.A. and Zoetis, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Veterinary Immunomodulators market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary Immunomodulators market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Immunomodulators market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Immunomodulators.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Veterinary Immunomodulators market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary Immunomodulators Market by Company

Biogenesis Bago

Boehringer Ingelheim Animal Health

Ceva Santé Animale

Elanco Animal Health

ImmunoVet Ltd.

MSD Animal Health

Phibro Animal Health Corporation

Vetoquinol S.A.

Zoetis, Inc.

Veterinary Immunomodulators Segment by Type

Injectable

Topical

Oral

Others

Veterinary Immunomodulators Segment by Application

Online Sales

Offline Sales

Veterinary Immunomodulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Immunomodulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Immunomodulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Immunomodulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Immunomodulators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Veterinary Immunomodulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectable Table 2. Major Company of Topical Table 3. Major Company of Oral Table 4. Major Company of Others Table 5. Global Veterinary Immunomodulators Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Veterinary Immunomodulators Sales by Type (2021-2026) & (Kg) Table 7. Global Veterinary Immunomodulators Sales Market Share in Volume by Type (2021-2026) Table 8. Global Veterinary Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 9. Global Veterinary Immunomodulators Sales Market Share in Value by Type (2021-2026) Table 10. Global Veterinary Immunomodulators Price by Type (2021-2026) & (US$/g) Table 11. Global Veterinary Immunomodulators Sales by Type (2027-2032) & (Kg) Table 12. Global Veterinary Immunomodulators Sales Market Share in Volume by Type (2027-2032) Table 13. Global Veterinary Immunomodulators Sales by Type (2027-2032) & (US$ Million) Table 14. Global Veterinary Immunomodulators Sales Market Share in Value by Type (2027-2032) Table 15. Global Veterinary Immunomodulators Price by Type (2027-2032) & (US$/g) Table 16. North America Veterinary Immunomodulators Sales by Type (2021-2026) & (Kg) Table 17. North America Veterinary Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Veterinary Immunomodulators Sales by Type (2021-2026) & (Kg) Table 19. Europe Veterinary Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Veterinary Immunomodulators Sales by Type (2021-2026) & (Kg) Table 21. Asia-Pacific Veterinary Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Veterinary Immunomodulators Sales by Type (2021-2026) & (Kg) Table 23. Latin America Veterinary Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Veterinary Immunomodulators Sales by Type (2021-2026) & (Kg) Table 25. Middle East and Africa Veterinary Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 26. Veterinary Immunomodulators Industry Trends Table 27. Veterinary Immunomodulators Industry Drivers Table 28. Veterinary Immunomodulators Industry Opportunities and Challenges Table 29. Veterinary Immunomodulators Industry Restraints Table 30. Global Veterinary Immunomodulators Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Veterinary Immunomodulators Revenue Market Share by Company (2021-2026) Table 32. Global Veterinary Immunomodulators Sales by Company (2021-2026) & (Kg) Table 33. Global Veterinary Immunomodulators Sales Share by Company (2021-2026) Table 34. Global Veterinary Immunomodulators Market Price by Company (2021-2026) & (US$/g) Table 35. Global Veterinary Immunomodulators Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Veterinary Immunomodulators Major Company Production Sites and Headquarters Table 37. Global Veterinary Immunomodulators Company, Product Type & Application Table 38. Global Veterinary Immunomodulators Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Veterinary Immunomodulators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Veterinary Immunomodulators Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Veterinary Immunomodulators Sales by Region (2021-2026) & (Kg) Table 43. Global Veterinary Immunomodulators Sales Market Share in Volume by Region (2021-2026) Table 44. Global Veterinary Immunomodulators Sales by Region (2021-2026) & (US$ Million) Table 45. Global Veterinary Immunomodulators Sales Market Share in Value by Region (2021-2026) Table 46. Global Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 47. Global Veterinary Immunomodulators Sales by Region (2027-2032) & (Kg) Table 48. Global Veterinary Immunomodulators Sales Market Share in Volume by Region (2027-2032) Table 49. Global Veterinary Immunomodulators Sales by Region (2027-2032) & (US$ Million) Table 50. Global Veterinary Immunomodulators Sales Market Share in Value by Region (2027-2032) Table 51. Global Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 52. Global Veterinary Immunomodulators Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Veterinary Immunomodulators Sales by Application (2021-2026) & (Kg) Table 54. Global Veterinary Immunomodulators Sales Market Share in Volume by Application (2021-2026) Table 55. Global Veterinary Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 56. Global Veterinary Immunomodulators Sales Market Share in Value by Application (2021-2026) Table 57. Global Veterinary Immunomodulators Price by Application (2021-2026) & (US$/g) Table 58. Global Veterinary Immunomodulators Sales by Application (2027-2032) & (Kg) Table 59. Global Veterinary Immunomodulators Sales Market Share in Volume by Application (2027-2032) Table 60. Global Veterinary Immunomodulators Sales by Application (2027-2032) & (US$ Million) Table 61. Global Veterinary Immunomodulators Sales Market Share in Value by Application (2027-2032) Table 62. Global Veterinary Immunomodulators Price by Application (2027-2032) & (US$/g) Table 63. North America Veterinary Immunomodulators Sales by Application (2021-2026) & (Kg) Table 64. North America Veterinary Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Veterinary Immunomodulators Sales by Application (2021-2026) & (Kg) Table 66. Europe Veterinary Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Veterinary Immunomodulators Sales by Application (2021-2026) & (Kg) Table 68. Asia-Pacific Veterinary Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Veterinary Immunomodulators Sales by Application (2021-2026) & (Kg) Table 70. Latin America Veterinary Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Veterinary Immunomodulators Sales by Application (2021-2026) & (Kg) Table 72. Middle East and Africa Veterinary Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 73. Biogenesis Bago Company Information Table 74. Biogenesis Bago Business Overview Table 75. Biogenesis Bago Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Biogenesis Bago Veterinary Immunomodulators Product Portfolio Table 77. Biogenesis Bago Recent Development Table 78. Boehringer Ingelheim Animal Health Company Information Table 79. Boehringer Ingelheim Animal Health Business Overview Table 80. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolio Table 82. Boehringer Ingelheim Animal Health Recent Development Table 83. Ceva Santé Animale Company Information Table 84. Ceva Santé Animale Business Overview Table 85. Ceva Santé Animale Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Ceva Santé Animale Veterinary Immunomodulators Product Portfolio Table 87. Ceva Santé Animale Recent Development Table 88. Elanco Animal Health Company Information Table 89. Elanco Animal Health Business Overview Table 90. Elanco Animal Health Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. Elanco Animal Health Veterinary Immunomodulators Product Portfolio Table 92. Elanco Animal Health Recent Development Table 93. ImmunoVet Ltd. Company Information Table 94. ImmunoVet Ltd. Business Overview Table 95. ImmunoVet Ltd. Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolio Table 97. ImmunoVet Ltd. Recent Development Table 98. MSD Animal Health Company Information Table 99. MSD Animal Health Business Overview Table 100. MSD Animal Health Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. MSD Animal Health Veterinary Immunomodulators Product Portfolio Table 102. MSD Animal Health Recent Development Table 103. Phibro Animal Health Corporation Company Information Table 104. Phibro Animal Health Corporation Business Overview Table 105. Phibro Animal Health Corporation Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolio Table 107. Phibro Animal Health Corporation Recent Development Table 108. Vetoquinol S.A. Company Information Table 109. Vetoquinol S.A. Business Overview Table 110. Vetoquinol S.A. Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 111. Vetoquinol S.A. Veterinary Immunomodulators Product Portfolio Table 112. Vetoquinol S.A. Recent Development Table 113. Zoetis, Inc. Company Information Table 114. Zoetis, Inc. Business Overview Table 115. Zoetis, Inc. Veterinary Immunomodulators Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 116. Zoetis, Inc. Veterinary Immunomodulators Product Portfolio Table 117. Zoetis, Inc. Recent Development Table 118. North America Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 119. North America Veterinary Immunomodulators Sales by Country (2021-2026) & (Kg) Table 120. North America Veterinary Immunomodulators Sales Market Share by Country (2021-2026) Table 121. North America Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (Kg) Table 122. North America Veterinary Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 123. North America Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Veterinary Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Veterinary Immunomodulators Market Share by Country (2021-2026) Table 126. North America Veterinary Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Veterinary Immunomodulators Market Share Forecast by Country (2027-2032) Table 128. Europe Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 129. Europe Veterinary Immunomodulators Sales by Country (2021-2026) & (Kg) Table 130. Europe Veterinary Immunomodulators Sales Market Share by Country (2021-2026) Table 131. Europe Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (Kg) Table 132. Europe Veterinary Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Veterinary Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Veterinary Immunomodulators Market Share by Country (2021-2026) Table 136. Europe Veterinary Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Veterinary Immunomodulators Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Veterinary Immunomodulators Sales by Country (2021-2026) & (Kg) Table 140. Asia-Pacific Veterinary Immunomodulators Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (Kg) Table 142. Asia-Pacific Veterinary Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Veterinary Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Veterinary Immunomodulators Market Share by Country (2021-2026) Table 146. Asia-Pacific Veterinary Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Veterinary Immunomodulators Market Share Forecast by Country (2027-2032) Table 148. Latin America Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 149. Latin America Veterinary Immunomodulators Sales by Country (2021-2026) & (Kg) Table 150. Latin America Veterinary Immunomodulators Sales Market Share by Country (2021-2026) Table 151. Latin America Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (Kg) Table 152. Latin America Veterinary Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Veterinary Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Veterinary Immunomodulators Market Share by Country (2021-2026) Table 156. Latin America Veterinary Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Veterinary Immunomodulators Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Veterinary Immunomodulators Sales by Country (2021-2026) & (Kg) Table 160. Middle East and Africa Veterinary Immunomodulators Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Veterinary Immunomodulators Sales Forecast by Country (2027-2032) & (Kg) Table 162. Middle East and Africa Veterinary Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Veterinary Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Veterinary Immunomodulators Market Share by Country (2021-2026) Table 166. Middle East and Africa Veterinary Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Veterinary Immunomodulators Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Veterinary Immunomodulators Distributors List Table 171. Veterinary Immunomodulators Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Veterinary Immunomodulators Image Figure 2. Global Veterinary Immunomodulators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Immunomodulators Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Immunomodulators Sales (2021-2032) & (Kg) Figure 5. Injectable Image Figure 6. Global Injectable Sales YoY Growth (2021-2032) & (Kg) Figure 7. Topical Image Figure 8. Global Topical Sales YoY Growth (2021-2032) & (Kg) Figure 9. Oral Image Figure 10. Global Oral Sales YoY Growth (2021-2032) & (Kg) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 13. Global Veterinary Immunomodulators Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Veterinary Immunomodulators Market Share by Type 2025 VS 2032 Figure 15. North America Veterinary Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 16. North America Veterinary Immunomodulators Sales Market Share in Value by Type in 2025 Figure 17. Europe Veterinary Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 18. Europe Veterinary Immunomodulators Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Veterinary Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Veterinary Immunomodulators Sales Market Share in Value by Type in 2025 Figure 21. Latin America Veterinary Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Veterinary Immunomodulators Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Veterinary Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Veterinary Immunomodulators Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Veterinary Immunomodulators Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Online Sales Image Figure 28. Global Online Sales Sales YoY Growth (2021-2032) & (Kg) Figure 29. Offline Sales Image Figure 30. Global Offline Sales Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Veterinary Immunomodulators Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Veterinary Immunomodulators Market Share by Application 2025 VS 2032 Figure 33. North America Veterinary Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 34. North America Veterinary Immunomodulators Sales Market Share in Value by Application in 2025 Figure 35. Europe Veterinary Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 36. Europe Veterinary Immunomodulators Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Veterinary Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Veterinary Immunomodulators Sales Market Share in Value by Application in 2025 Figure 39. Latin America Veterinary Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Veterinary Immunomodulators Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Veterinary Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Veterinary Immunomodulators Sales Market Share in Value by Application in 2025 Figure 43. North America Veterinary Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Veterinary Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Veterinary Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Veterinary Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Veterinary Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Veterinary Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Veterinary Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Veterinary Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Veterinary Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Veterinary Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Veterinary Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Veterinary Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Veterinary Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Veterinary Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Veterinary Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Veterinary Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Veterinary Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Veterinary Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Veterinary Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Veterinary Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Veterinary Immunomodulators Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Veterinary Immunomodulators Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable
  • Topical
  • Oral
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Biogenesis Bago
  • Boehringer Ingelheim Animal Health
  • Ceva Santé Animale
  • Elanco Animal Health
  • ImmunoVet Ltd.
  • MSD Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Zoetis, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Immunomodulators Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Veterinary Immunomodulators Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Veterinary Immunomodulators Market by Type
  6. 1.3.1 Injectable
  7. 1.3.2 Topical
  8. 1.3.3 Oral
  9. 1.3.4 Others
  10. 1.4 Global Veterinary Immunomodulators Market Size by Type
  11. 1.4.1 Global Veterinary Immunomodulators Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Veterinary Immunomodulators Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Veterinary Immunomodulators Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Veterinary Immunomodulators Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Veterinary Immunomodulators Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Veterinary Immunomodulators Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Veterinary Immunomodulators Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Veterinary Immunomodulators Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Veterinary Immunomodulators Industry Trends
  2. 2.2 Veterinary Immunomodulators Industry Drivers
  3. 2.3 Veterinary Immunomodulators Industry Opportunities and Challenges
  4. 2.4 Veterinary Immunomodulators Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Veterinary Immunomodulators Revenue (2021-2026)
  2. 3.2 Global Top Players by Veterinary Immunomodulators Sales (2021-2026)
  3. 3.3 Global Top Players by Veterinary Immunomodulators Price (2021-2026)
  4. 3.4 Global Veterinary Immunomodulators Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Immunomodulators Major Company Production Sites & Headquarters
  6. 3.6 Global Veterinary Immunomodulators Company, Product Type & Application
  7. 3.7 Global Veterinary Immunomodulators Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Immunomodulators Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Immunomodulators Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Immunomodulators Tier 1, Tier 2, and Tier 3
4 Veterinary Immunomodulators Regional Status and Outlook
  1. 4.1 Global Veterinary Immunomodulators Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Veterinary Immunomodulators Historic Market Size by Region
  3. 4.2.1 Global Veterinary Immunomodulators Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Veterinary Immunomodulators Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Veterinary Immunomodulators Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Veterinary Immunomodulators Forecasted Market Size by Region
  7. 4.3.1 Global Veterinary Immunomodulators Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Veterinary Immunomodulators Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Veterinary Immunomodulators Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary Immunomodulators by Application
  1. 5.1 Veterinary Immunomodulators Market by Application
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Veterinary Immunomodulators Market Size by Application
  5. 5.2.1 Global Veterinary Immunomodulators Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Veterinary Immunomodulators Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Veterinary Immunomodulators Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Veterinary Immunomodulators Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Veterinary Immunomodulators Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Veterinary Immunomodulators Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Veterinary Immunomodulators Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Veterinary Immunomodulators Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biogenesis Bago
  2. 6.1.1 Biogenesis Bago Company Information
  3. 6.1.2 Biogenesis Bago Business Overview
  4. 6.1.3 Biogenesis Bago Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biogenesis Bago Veterinary Immunomodulators Product Portfolio
  6. 6.1.5 Biogenesis Bago Recent Developments
  7. 6.2 Boehringer Ingelheim Animal Health
  8. 6.2.1 Boehringer Ingelheim Animal Health Company Information
  9. 6.2.2 Boehringer Ingelheim Animal Health Business Overview
  10. 6.2.3 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Animal Health Recent Developments
  13. 6.3 Ceva Santé Animale
  14. 6.3.1 Ceva Santé Animale Company Information
  15. 6.3.2 Ceva Santé Animale Business Overview
  16. 6.3.3 Ceva Santé Animale Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ceva Santé Animale Veterinary Immunomodulators Product Portfolio
  18. 6.3.5 Ceva Santé Animale Recent Developments
  19. 6.4 Elanco Animal Health
  20. 6.4.1 Elanco Animal Health Company Information
  21. 6.4.2 Elanco Animal Health Business Overview
  22. 6.4.3 Elanco Animal Health Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Elanco Animal Health Veterinary Immunomodulators Product Portfolio
  24. 6.4.5 Elanco Animal Health Recent Developments
  25. 6.5 ImmunoVet Ltd.
  26. 6.5.1 ImmunoVet Ltd. Company Information
  27. 6.5.2 ImmunoVet Ltd. Business Overview
  28. 6.5.3 ImmunoVet Ltd. Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolio
  30. 6.5.5 ImmunoVet Ltd. Recent Developments
  31. 6.6 MSD Animal Health
  32. 6.6.1 MSD Animal Health Company Information
  33. 6.6.2 MSD Animal Health Business Overview
  34. 6.6.3 MSD Animal Health Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MSD Animal Health Veterinary Immunomodulators Product Portfolio
  36. 6.6.5 MSD Animal Health Recent Developments
  37. 6.7 Phibro Animal Health Corporation
  38. 6.7.1 Phibro Animal Health Corporation Company Information
  39. 6.7.2 Phibro Animal Health Corporation Business Overview
  40. 6.7.3 Phibro Animal Health Corporation Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolio
  42. 6.7.5 Phibro Animal Health Corporation Recent Developments
  43. 6.8 Vetoquinol S.A.
  44. 6.8.1 Vetoquinol S.A. Company Information
  45. 6.8.2 Vetoquinol S.A. Business Overview
  46. 6.8.3 Vetoquinol S.A. Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Vetoquinol S.A. Veterinary Immunomodulators Product Portfolio
  48. 6.8.5 Vetoquinol S.A. Recent Developments
  49. 6.9 Zoetis, Inc.
  50. 6.9.1 Zoetis, Inc. Company Information
  51. 6.9.2 Zoetis, Inc. Business Overview
  52. 6.9.3 Zoetis, Inc. Veterinary Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zoetis, Inc. Veterinary Immunomodulators Product Portfolio
  54. 6.9.5 Zoetis, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Veterinary Immunomodulators Sales by Country
  2. 7.1.1 North America Veterinary Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Veterinary Immunomodulators Sales by Country (2021-2026)
  4. 7.1.3 North America Veterinary Immunomodulators Sales Forecast by Country (2027-2032)
  5. 7.2 North America Veterinary Immunomodulators Market Size by Country
  6. 7.2.1 North America Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Veterinary Immunomodulators Market Size by Country (2021-2026)
  8. 7.2.3 North America Veterinary Immunomodulators Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Veterinary Immunomodulators Sales by Country
  2. 8.1.1 Europe Veterinary Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Veterinary Immunomodulators Sales by Country (2021-2026)
  4. 8.1.3 Europe Veterinary Immunomodulators Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Veterinary Immunomodulators Market Size by Country
  6. 8.2.1 Europe Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Veterinary Immunomodulators Market Size by Country (2021-2026)
  8. 8.2.3 Europe Veterinary Immunomodulators Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Veterinary Immunomodulators Sales by Country
  2. 9.1.1 Asia-Pacific Veterinary Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Veterinary Immunomodulators Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Veterinary Immunomodulators Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Veterinary Immunomodulators Market Size by Country
  6. 9.2.1 Asia-Pacific Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Veterinary Immunomodulators Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Veterinary Immunomodulators Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Veterinary Immunomodulators Sales by Country
  2. 10.1.1 South America Veterinary Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Veterinary Immunomodulators Sales by Country (2021-2026)
  4. 10.1.3 South America Veterinary Immunomodulators Sales Forecast by Country (2027-2032)
  5. 10.2 South America Veterinary Immunomodulators Market Size by Country
  6. 10.2.1 South America Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Veterinary Immunomodulators Market Size by Country (2021-2026)
  8. 10.2.3 South America Veterinary Immunomodulators Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Veterinary Immunomodulators Sales by Country
  2. 11.1.1 Middle East and Africa Veterinary Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Veterinary Immunomodulators Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Veterinary Immunomodulators Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Veterinary Immunomodulators Market Size by Country
  6. 11.2.1 Middle East and Africa Veterinary Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Veterinary Immunomodulators Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Veterinary Immunomodulators Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Veterinary Immunomodulators Value Chain Analysis
  2. 12.1.1 Veterinary Immunomodulators Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Veterinary Immunomodulators Production Mode & Process
  7. 12.2 Veterinary Immunomodulators Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Veterinary Immunomodulators Distributors
  10. 12.2.3 Veterinary Immunomodulators Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst